The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses

Mycoses

Volumn 51, Issue SUPPL.4, 2008, Pages 16-26

  Havlickova, Blanka ^a   Friedrich, Markus ^a  

^a Intendis GmbH   (Germany)

Author keywords

Diflucortolone valerate; Isoconazole nitrate; Tinea infections

Indexed keywords

10 UNDECENOIC ACID; ALLYLAMINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BENZYLAMINE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE PLUS CLOTRIMAZOLE; BETAMETHASONE VALERATE; BUTENAFINE; BUTOCONAZOLE; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CORTICOSTEROID; CROCONAZOLE; DIFLUCORTOLONE VALERATE; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; GRISEOFULVIN; IMIDAZOLE; ISOCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NAFTIFINE; NYSTATIN; OXICONAZOLE; SULCONAZOLE; TERBINAFINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AEROSOL; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CREAM; DERMATOMYCOSIS; DRUG EFFICACY; DRUG INDICATION; DRUG STRUCTURE; DRUG TOLERABILITY; EPIDERMOPHYTON; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; LIVER TOXICITY; LUPUS ERYTHEMATOSUS; MICROSPORUM; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; PRURITUS; RISK BENEFIT ANALYSIS; SKIN INFLAMMATION; SKIN IRRITATION; TELANGIECTASIA; TINEA CAPITIS; TINEA CRURIS; TINEA MANUUM; TINEA PEDIS; TREATMENT OUTCOME; TRICHOPHYTON;

ADMINISTRATION, CUTANEOUS; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DERMATOMYCOSES; DIFLUCORTOLONE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMANS; INFLAMMATION; MICONAZOLE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TINEA; TREATMENT OUTCOME;

EPIDERMOPHYTON; MICROSPORUM; TINEA CRURIS; TRICHOPHYTON;

EID: 50649093080     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2008.01615.x     Document Type: Article

References (23)

1. Nobel SM, Forbes RC, Stamm PL. Diagnosis and management of common tinea infections. Am Fam Physician 1998 58 : 163 4.
2. Borman AM, Campbell CK, Fraser M, Johson EM. Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades. Med Mycol 2007 45 : 131 41.
3. Hay R. Skin diseases. In : Jamison DT, Breman AG, Measham AR et al. (eds Disease Control Priorities in Developing Countries, 2nd edn, Chapter 37. New York : The World Bank and Oxford University Press, 2006 : 707 21.
4. Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol 1994 31 : S21 5.
5. Nelson MM, Martin AG, Hefferman MP. Superficial fungal infections: dermatophytosis, onychomycosis, tinea nigra, piedra. In : Fitzpatrick TB (ed Dermatology in General Medicine, Vol. 2. New York : McGraw-Hill, 2003 : 1989 2005.
6. Quandt SA, Schulz MR, Vallejos QM et al. The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant workers. Int J Dermatol 2008 47 : 236 41.
7. Fitzpatrick JE. Topical antifungal agents. In : Fitzpatrick TB (ed Dermatology in General Medicine, Vol. 2. New York : McGraw-Hill, 2003 : 2339 43.
8. Huang DB, Ostrosky-Zeichner L, Wu JJ, Pang KR, Tyring SK. Therapy of common superficial fungal infections. Dermatol Ther 2004 17 : 517 22.
9. Hoppe G. Investigations with an Antimycotic/Corticoid Combination Compared to Plain Antimycotic Preparations. Singapore : 6th Regional Conference of Dermatology (Asian-Australasian), 1984.
10. Sud IJ, Feingold DS. Mechanisms of action of the antimycotic imidazoles. J Invest Dermatol 1981 76 : 438 41.
11. Kessler H-J. Microbiological studies with isoconazole nitrate, a broad-spectrum antimycotic from the group of imidazole derivatives. Drug Res 1979 29 : 1344 51.
12. Herms E, Kallischnigg G. Once daily administration of isoconazole as a cream, solution and spray: comparative studies of patients with dermatomycoses. Z Hautkr 1988 63 : 377 84.
13. Gugnani HC, Akpata LE, Gugnani MK, Srivastava R. Isoconazole nitrate in the treatment of tropical dermatomycoses. Mycoses 1994 37 : 39 41.
14. Hernández-Molina JM, Llosá J, Martinez Brocal A, Ventosa A. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp. Mycopathologia 1992 118 : 15 21.
15. Täuber U, Rzadkiewicz M. Bioavailability of isoconazole in the skin. Mykosen 1979 22 : 21 16.
16. Dykes PJ, Marks R, Täuber U. The retention of isoconazole in the skin after once or twice daily application of 1% isoconazole nitrate cream (Travogen) over a 14-day period. Clin Exp Dermatol 1986 11 : 365 70.
17. Hoppe G. Diflucortolone valerate. Asian experience. Drugs 1988 36 (Suppl. 5 24 33.
18. Tauber VU, Amin M, Fuchs P, Speck U. Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide. Arzneimittelforschung 1976 26 : 1492 5.
19. Frosch PJ, Behrenbeck E-M, Frosch K, Macher E. The Duhring chamber assay for corticosteroid therapy. Br J Dermatol 1981 104 : 56 65.
20. Weitgasser H, Herms E. Comparative clinical investigations with the new antimycotic agent isoconazole nitrate and its combination with diflucortolone-21-valerate in the case of inflammatory and eczematised dermatomycoses. Mykosen 1979 22 : 177 83.
21. Nolting S, Langen ML. Are topical corticoids advantageous and justifiable in the treatment of dermatomycoses? (Travocort cream and Travogen cream were compared in 100 patients in an interindividual double-blind trial)] Mykosen 1980 23 : 699 706.
22. ® Cream. Multicentre Clinical Studies of 525 Patients With Inflammatory Dermatomycoses in 12 Dermatological Practices in Germany. Amsterdam : Excerpta Medica, 1981. Workshop Results, June 15, 1979.
23. Gip L, Langen ML. Results of a contralateral comparative study between Travocort cream and Travogen cream in inflammatory and allergic dermatomycoses. Mykosen 1980 23 : 79 84.